Circulating levels of MALAT1 were elevated in HCC samples (9.17 ± 43.62) compared to individuals with hepatic disease (1.10 ± 0.82) and healthy controls (0.85 ± 1.10). This evidence concerns the gene MALAT1 and hepatocellular carcinoma.